Crohn disease

Related records

Broader conditions (10)

• Digestive system disorder
• Disease
• Disease by body system or component
• Disease by etiologic mechanism
• Disease of genetic or genomic mechanism
• Hereditary disease
• Human disease
• Immune system disorder
• Inflammatory bowel disease
• Intestinal disorder

Narrower conditions (10)

• Crohn disease of the esophagus
• Crohn ileitis
• Crohn jejunitis
• Crohn jejunoileitis
• Crohn's colitis
• Gastroduodenal Crohn disease
• Ileocolitis
• Oral Crohn disease
• Perianal Crohn disease
• Small bowel Crohn disease

Trials (1,924)

• "Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial"
• "Tasty&Healthy" Dietary Approach for Crohn's Disease
• 18F-FDG and 68Ga-FAPI PET/CT in Crohn's Disease
• 5-HTP in Patients With IBD in Clinical and Biologic Remission:Effect on Fatigue Scores
• 68Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease
• 9 mg Budesonide Once Daily (OD) Versus 3 mg Budesonide Three Times Daily (TID) in Active Crohn's Disease
• 90Second IBD for the Improvement of Self Efficacy and Quality of Life in Inflammatory Bowel Disease Patients
• A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
• A Blood and Tissue Sample Collection Study of Patients Who Have Inflammatory Bowel Disease, Who Have Been Treated With Adalimumab and Who Developed Hepatosplenic T-Cell Lymphoma
• A Brief Intervention to Improve Adherence in Teens With Inflammatory Bowel Disease
• A Clinical Study on The Use of DL-endopeptidase-producing Probiotics as an Adjunctive Therapy for Inflammatory Bowel Disease.
• A Clinical Study With Adalimumab Biosimilar
• A Clinical Trial of Antibody GSK1070806 in the Treatment of Patients With Moderate to Severe Crohn's Disease
• A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease
• A Comparative Study of Capsule Endoscopy, Magnetic Resonance Imaging and Computer Tomography Scanning of the Small Bowel in Crohn's Disease
• A Comparative Study of MRI, US and CE for Assessing Treatment Response in Known Crohn's Disease
• A Comparison of Ultrasound Guided Transversus Abdominis Plane Nerve Block Techniques
• A Comprehensive Self-Management Intervention for Individuals With Inflammatory Bowel Disease
• A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
• A Crohn's Disease Diet to Reduce Symptoms of Crohn's Disease

Approved drugs (14)

• Adalimumab
• Budesonide
• Certolizumab pegol
• Dexamethasone
• Dexamethasone sodium phosphate
• Hydrocortisone
• Infliximab
• Methylprednisolone
• Mirikizumab
• Natalizumab
• Prednisolone
• Prednisone
• Ustekinumab
• Vedolizumab

Drugs in development (156)

• 2'-fucosyllactose Phase 1
• Abatacept Phase 3
• Abrilumab Phase 2
• Acetaminophen Phase 1
• Adalimumab fosimdesonide Phase 2
• Afimkibart Phase 2
• Aldesleukin Phase 2
• Alemtuzumab Phase 2
• Alicaforsen Phase 3
• Aminolevulinic acid Phase 1
• Aminosalicylic acid Phase 2
• Amiselimod hydrochloride Phase 2
• Andecaliximab Phase 2
• Andrographolide Phase 2
• Apilimod Phase 2
• Apilimod mesylate Phase 2
• Artesunate Phase 2
• Atorvastatin Phase 2
• Azathioprine Phase 3
• Azithromycin Phase 2

Other linked drugs (8)

• Betadex
• Certolizumab
• Citric acid
• Icotrokinra
• Magnesium oxide
• Pravastatin
• Sirolimus
• Sodium picosulfate